MedPath

Karius, Inc.

🇺🇸United States
Ownership
-
Employees
-
Market Cap
-
Website

Clinical Trials

8

Active:1
Completed:7

Trial Phases

0 Phases

Drug Approvals

0

Drug Approvals

No drug approvals found

This company may not have drug approvals in our database

Clinical Trials

Pneumonia in the ImmunoCompromised - Use of the Karius Test for the Detection of Undiagnosed Pathogens

Completed
Conditions
Pneumonia Fungal
Pneumonia, Bacterial
Pneumonia, Viral
Pneumonia Cavitary
Immunocompromised Host
First Posted Date
2019-08-07
Last Posted Date
2023-02-09
Lead Sponsor
Karius, Inc.
Target Recruit Count
257
Registration Number
NCT04047719
Locations
🇺🇸

City of Hope Comprehensive Cancer Center, Duarte, California, United States

🇺🇸

UCSF Department of Medicine, San Francisco, California, United States

🇺🇸

University of Colorado Denver, Aurora, Colorado, United States

and more 7 locations

Detection of Dengue Virus in Plasma of Patients in Nepal

Completed
Conditions
Dengue Fever
First Posted Date
2018-08-08
Last Posted Date
2023-02-14
Lead Sponsor
Karius, Inc.
Target Recruit Count
643
Registration Number
NCT03620487
Locations
🇳🇵

Tribhuvan University, Kirtipur, Nepal

Use of NGS Cell-free Pathogen Test for Identification of Low Risk Fever & Neutropenia in Pediatric Patients

Completed
Conditions
Neutropenia
Fever
First Posted Date
2018-05-21
Last Posted Date
2023-02-10
Lead Sponsor
Karius, Inc.
Target Recruit Count
15
Registration Number
NCT03530072
Locations
🇺🇸

Lucille Packard Children's Hopsital, Stanford, California, United States

Evaluation of NGS for Detection and Follow-up of Fungal Pathogens in Immunocompromised Pediatric Patients

Completed
Conditions
Invasive Fungal Infections
Invasive Fungal Disease
Fever and Neutropenia
Immunocompromised
First Posted Date
2017-08-25
Last Posted Date
2019-06-17
Lead Sponsor
Karius, Inc.
Target Recruit Count
40
Registration Number
NCT03262584
Locations
🇺🇸

Ann & Robert H. Lurie Children's Hospital of Chicago, Chicago, Illinois, United States

Diagnosis of Bacteremia/Septicemia and Culture Negative Endocarditis by the Karius Sequencing-Based Infectious Disease Diagnostic Assay

Completed
Conditions
Septicemia
Bacteremia
First Posted Date
2016-12-09
Last Posted Date
2018-05-11
Lead Sponsor
Karius, Inc.
Target Recruit Count
108
Registration Number
NCT02988414
Locations
🇺🇸

Duke University Hospital, Durham, North Carolina, United States

  • Prev
  • 1
  • 2
  • Next

News

No news found
© Copyright 2025. All Rights Reserved by MedPath
HomeTerms & ConditionsPrivacy Policy